| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/26/2005 | CA2080118C Antigen/anti-antigen cleavage |
| 07/26/2005 | CA2076961C Igg-1 human monoclonal antibody reactive with an hiv-1 glycoprotein and method of use |
| 07/21/2005 | WO2005066332A1 Serum-free vero cell banking process |
| 07/21/2005 | WO2005066331A1 Dry powder cells and cell culture reagents and methods of production thereof |
| 07/21/2005 | WO2005066330A1 A system for improving acceptance of tissue grafts made from embryonic stem cells |
| 07/21/2005 | WO2005066329A1 Microinjection of cryoprotectants for preservation of cells |
| 07/21/2005 | WO2005065710A1 Autoantibodies utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment |
| 07/21/2005 | WO2005065704A1 Preventive and remedy for bone disease |
| 07/21/2005 | WO2005065419A2 Method of culturing cells |
| 07/21/2005 | WO2005065418A2 Compositions and methods of use of targeting peptides for diagnosis and therapy |
| 07/21/2005 | WO2005065384A2 Electronic trading data integration and protection system |
| 07/21/2005 | WO2005065354A2 Defined media for pluripotent stem cell culture |
| 07/21/2005 | WO2005065341A2 Dry powder cells and cell culture reagents and methods of production thereof |
| 07/21/2005 | WO2005065309A2 Lentiviral vector delivery of native and mutated igfbp-3 for treatment of cancer |
| 07/21/2005 | WO2005065242A2 Method of treating cancer using platelet releasate |
| 07/21/2005 | WO2005065015A2 Neutralizing antibodies and methods of use thereof |
| 07/21/2005 | WO2005030251A8 Compositions and methods to accelerate hematologic recovery |
| 07/21/2005 | WO2005012351A3 Novel functions for decay accelerating factor (daf) in inflammation |
| 07/21/2005 | WO2004024064A8 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2005 | WO2003085095A3 Novel expressed genes |
| 07/21/2005 | WO2003057160A8 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2005 | US20050160506 Hybrid corn plants, tissue culture of regenerable cells , protoplasts, male sterile maize plant , produced by cross breeding, genetic engineering transformation, with herbicide resistance, disease resistance, high waxy starch and amylose starch |
| 07/21/2005 | US20050160505 Inbred corn line PHCWK |
| 07/21/2005 | US20050160503 Transgenic seeds which generate diseaase, herbicide and insect resistant plants; enhanced storage stability; improving crop plants |
| 07/21/2005 | US20050160487 Having a lesser leaf angle compared to the leaf angle of inbred maize line A619 and when crossed with other inbred maize lines produce hybrids having excellent root lodging. |
| 07/21/2005 | US20050160482 Drug screening; dopamine/neurotransmitter transporters; green/yellow/blue fluorescent protein; spectrum analysis |
| 07/21/2005 | US20050159591 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2005 | US20050159588 Nucleotide sequences coding tumor-associated antigenic target polypeptides; diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents |
| 07/21/2005 | US20050159373 Novel polypeptides, and nucleic acids encoding the same |
| 07/21/2005 | US20050159332 Ntb-a,a a surface molecule involved in natural killer cellss activity |
| 07/21/2005 | US20050158860 Method for evolving a cell having desired phenotype and evolved cells |
| 07/21/2005 | US20050158859 Manipulation of non-terminally differentiated cells using the Notch pathway |
| 07/21/2005 | US20050158857 Hematopoietic stem cell identification and isolation |
| 07/21/2005 | US20050158856 Methods for producing functional antigen presenting dendritic cells using biodegradable microparticles for delivery of antigenic materials |
| 07/21/2005 | US20050158855 Use of TGF beta superfamily antagonists to make dopaminergic neurons from embryonic stem cells |
| 07/21/2005 | US20050158854 Pluripotent human progenitor cell culture for use tool in organ replacement; regenerative medicine; tissue engineering |
| 07/21/2005 | US20050158853 Multipotent tissue culture for use in cell therapy treatments for diabetes mellitus and nervous system disorders |
| 07/21/2005 | US20050158852 Methods for culturing human embryonic stem cells |
| 07/21/2005 | US20050158846 Tissue propagation chamber which codes collected cells and cultures predetermined cells collected from patient and supplies cultured donor cells to original patient; infection testing |
| 07/21/2005 | US20050158832 Secreted glycoprotein hormone fusion for use in regulating the level of red blood cells in circulation |
| 07/21/2005 | US20050158826 Using tumor necrosis factor receptor releasing enzyme as therapeutic tool in treatment of inflammation, arthritis, rheumatoid arthritis and multiple sclerosis |
| 07/21/2005 | US20050158818 Recombinant hydrolase for use in the preparation of 7-amino-cephalosporanic acid; bioreactors |
| 07/21/2005 | US20050158803 binding antibody to substrate; neutralization of infection prions; in vivo diagnosis testing |
| 07/21/2005 | US20050158800 Detecting the expression of a G-protein coupled receptor, identifying agonists or antagonists of the receptor |
| 07/21/2005 | US20050158799 TRIF-related adaptor molecule (TRAM) and uses thereof |
| 07/21/2005 | US20050158784 Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof |
| 07/21/2005 | US20050158769 Using vector transformed cell as bioreactor vehicle for heterologous gene expression; directed protein evolution |
| 07/21/2005 | US20050158764 Alternatively spliced juvenile hormone receptor genes for use in identifying modulators for insect propagation; biological pest control |
| 07/21/2005 | US20050158753 Using presence of gastrointestinal system protein (CS141) as diagnostic indcator of gastrointestinal disorders; diagnosing colon and rectum cancer |
| 07/21/2005 | US20050158724 Methods, of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof |
| 07/21/2005 | US20050158721 Using overexpression of senescence-associated genes as diagnostic/prognostic indicator of organ rejection/failure |
| 07/21/2005 | US20050158707 Full - length genomic RNA of papaya leaf - distortion mosaic virus |
| 07/21/2005 | US20050158706 Methods and compositions for the differentiation of human preadipocytes into adipocytes |
| 07/21/2005 | US20050158699 Cryopreservation of plant cells |
| 07/21/2005 | US20050158423 Method of improving food fermentation procedures |
| 07/21/2005 | US20050158413 Useful in increasing the effects of nucleic acid vaccines and medicaments; in production of phenotypically immature and/or mature dendritic and/or fibrocyte cells |
| 07/21/2005 | US20050158397 Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors |
| 07/21/2005 | US20050158358 Tissue engineering scaffolds promoting matrix protein production |
| 07/21/2005 | US20050158357 Polymer tether covalently coupled to the scaffold; and a matrix-enhancing molecule that is covalently coupled to the polymer tether, such as ascorbic acid, angiotensin II, and/or insulin-like growth factor, to elicit production of extracellular matrix by a cell attached to the scaffold |
| 07/21/2005 | US20050158345 ABC (ATP-binding cassette) transporters; polynucleotides, expression vectors, transformed host cells and antibodies; use in vaccination |
| 07/21/2005 | US20050158328 Antigen presenting cells; immunogens; frozen container |
| 07/21/2005 | US20050158323 Via antibodies specific for antigen C35; host cells |
| 07/21/2005 | US20050158317 Novel proteins with il-6 inhibiting activity |
| 07/21/2005 | US20050158315 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 07/21/2005 | US20050158310 Via modulating insulin receptor signaling in adipocyte tissue; transgenic/knockout animal; RNA interference |
| 07/21/2005 | US20050158289 Mesenchymal precursor cell and use thereof in the repair of bone defects and fractures in mammals |
| 07/21/2005 | US20050158288 Methods of organ regeneration |
| 07/21/2005 | US20050158287 Methods for using the obese gene and its gene product to identify hematopoietic progenitor cells |
| 07/21/2005 | US20050158286 Differentiation of specialized dermal and epidermal cells into neuronal cells |
| 07/21/2005 | US20050158285 Transmission of electromagnetic signals from embryonic stem cells to adult stem cells provides molecular information of embryonic environment, which induces aged adult stem cells functioning as young cells; reactivating silenced genes in the mammal prior to transmitting the electromagnetic signals |
| 07/21/2005 | US20050158244 Cell population from staining a neoplastic cell population with a first marker, staining a dendritic cell population with a second marker, fusing the cells to obtain hybrid cell population stained with both markers; purifying |
| 07/21/2005 | US20050156378 Tissue preservation media |
| 07/21/2005 | DE10361444A1 Verfahren zur in vitro Differenzierung neuronaler Stammzellen oder von neuronalen Stammzellen abgeleiteter Zellen A method for in vitro differentiation of neural stem cells derived from neural stem cells or cells |
| 07/21/2005 | DE10024383B4 Mit toxischen Substanzen beladene dendritische Zellen With toxic substances loaded dendritic cells |
| 07/21/2005 | CA2552188A1 Polypeptides and immunogenic conjugates capable of inducing antibodies against pathogens, and uses thereof |
| 07/21/2005 | CA2551913A1 Autoantibodies utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment |
| 07/21/2005 | CA2551812A1 Electronic trading data integration and protection system |
| 07/21/2005 | CA2548990A1 Toll-like receptor 4 (tlr4)-neutralizing antibodies |
| 07/21/2005 | CA2548162A1 Serum-free vero cell banking process |
| 07/20/2005 | EP1555319A2 Modified nucleic acid sequences and method to increasing mRNA levels and protein expression in cell systems |
| 07/20/2005 | EP1555318A2 Hematopoietic cytokine receptor |
| 07/20/2005 | EP1555317A1 Synthetic genes and genetic constructs comprising the same |
| 07/20/2005 | EP1555316A2 Antigen library immunization |
| 07/20/2005 | EP1555314A2 Enzymes and detergent compositions |
| 07/20/2005 | EP1554931A1 Means for in vitro activating cell nuclei |
| 07/20/2005 | EP1554572A2 Compositions and methods for modulating blood-brain barrier transport |
| 07/20/2005 | EP1554393A2 P27 prevents cellular migration |
| 07/20/2005 | EP1554378A2 Proteases producing an altered immunogenic response and methods of making and using the same |
| 07/20/2005 | EP1554377A2 Thermostable reverse transcriptases and uses thereof |
| 07/20/2005 | EP1554374A1 Procedure for the large-scale t-lymphocytes culture in a homogeneous system |
| 07/20/2005 | EP1554373A2 Human foreskin cells suitable for culturing stem cells |
| 07/20/2005 | EP1554313A1 Regulation of the cre recombinase using a dissociation/re-association system of said recombinase |
| 07/20/2005 | EP1554016A2 In vitro synchronisation of nuclear and cytoplasmatic maturation of oocytes involving addition and removal of phosphodiesterase type 3 inhibitor |
| 07/20/2005 | EP1553982A2 METHODS AND COMPOSITIONS FOR MODULATING T HELPER (T sb H /sb ) CELL DEVELOPMENT AND FUNCTION |
| 07/20/2005 | EP1553978A2 Interacting site for gp41 on gp120 of hiv-1 |
| 07/20/2005 | EP1553976A2 Hiv envelope-cd4 complexes and hybrids |
| 07/20/2005 | EP1553912A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/20/2005 | EP1553893A2 Implantation of encapsulated biological materials for treating diseases |
| 07/20/2005 | EP1553833A2 Cardiac muscle regeneration using mesenchymal stem cells |
| 07/20/2005 | EP1553832A2 Cell separation compositions and methods |